Roche Holding AG

OTC: RHHBY · Real-Time Price · USD
39.57
0.91 (2.35%)
At close: Aug 15, 2025, 9:42 AM

Roche Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
89.47B 89.7B 93.06B 95.37B 95.1B 91.84B 89.04B
Cost of Revenue
23.29B 24.91B 26.38B 29.3B 29.45B 28.16B 25.6B
Gross Profit
66.18B 64.8B 66.69B 66.07B 65.64B 63.68B 63.44B
Operating Income
27.2B 24.25B 27.63B 26.23B 27.55B 25.16B 26.95B
Interest Income
633M 947M 907M 742M 431M 179M 19M
Pretax Income
22.36B 19.48B 25.56B 23.88B 28.4B 25.18B 27.85B
Net Income
17.76B 15.39B 19.56B 18.55B 22.46B 20.15B 22.1B
Selling & General & Admin
19.37B 19.57B 18.42B 18.44B 17.43B 18.07B 17.28B
Research & Development
19.5B 20.65B 20.34B 21.07B 20.34B 20.07B 18.84B
Other Expenses
n/a n/a n/a -136M -136M -280M -265M
Operating Expenses
39.19B 40.54B 39.05B 39.84B 38.09B 38.52B 36.49B
Interest Expense
1.54B 1.18B 1.01B 778M 599M 550M 609M
Selling & Marketing Expenses
n/a n/a n/a 5.17B 9.48B 14.35B 13.7B
Cost & Expenses
62.64B 65.45B 65.43B 69.14B 67.54B 66.68B 62.09B
Income Tax Expense
3.25B 2.69B 4.41B 3.59B 4.29B 3.64B 4.57B
Shares Outstanding (Basic)
6.39B 6.38B 6.39B 6.39B 6.47B 6.76B 6.83B
Shares Outstanding (Diluted)
6.43B 6.43B 6.43B 6.39B 6.48B 6.86B 6.9B
EPS (Basic)
2.78 2.41 3.04 2.83 3.37 2.96 3.23
EPS (Diluted)
2.76 2.40 3.04 2.82 3.34 2.93 3.20
EBITDA
28.94B 26.05B 32.14B 30.66B 35.35B 32.55B 35.31B
EBIT
23.82B 20.66B 26.57B 24.66B 29B 25.73B 28.46B
Depreciation & Amortization
5.13B 5.39B 5.57B 6B 6.35B 6.82B 6.84B